Comparison of the efficacy and tolerability of two piroxicam betadex doses (20mg and 40mg) for the prevention of mild-to-moderate postoperative pain in patients undergoing functional endoscopic sinus surgery.
Phase of Trial: Phase II
Latest Information Update: 15 Feb 2011
At a glance
- Drugs Piroxicam betadex (Primary)
- Indications Postoperative pain
- Focus Adverse reactions; Therapeutic Use
- 15 Feb 2011 New trial record